Cordlife Sciences India Fined Rs 2.16 Lakh for Discarding Cord Blood
Parents win compensation after company throws away newborn's cord blood sample. Consumer commission orders refund and penalty.

A consumer commission has ordered Cordlife Sciences India to pay a total of Rs 2.16 lakh to a couple after the company discarded their newborn's cord blood sample due to delayed payment. The incident occurred when the couple failed to make a payment on time, resulting in the company disposing of the valuable sample.
The consumer commission found that Cordlife Sciences India acted unfairly and engaged in unfair trade practices. According to the commission, the couple never refused to make the payment and were not given a chance to settle their dues before the sample was discarded.
The commission's order directed Cordlife Sciences India to refund the initial payment made by the couple, as well as pay compensation and costs. This decision highlights the importance of companies acting fairly and transparently in their dealings with customers, especially in sensitive matters such as the storage of cord blood samples.
Cord blood banking is a process where the blood from a newborn's umbilical cord is collected and stored for potential future medical use. This blood is rich in stem cells, which can be used to treat various diseases. Many parents opt for cord blood banking as a form of insurance against future medical needs.
In this case, the couple had chosen to store their newborn's cord blood sample with Cordlife Sciences India, but due to unforeseen circumstances, they were unable to make a payment on time. Despite this, the company went ahead and discarded the sample without giving the couple a chance to settle their dues.
The consumer commission's decision is a significant victory for the couple, who had lost a valuable resource due to the company's actions. It also serves as a warning to companies engaged in cord blood banking and other sensitive services to act fairly and transparently in their dealings with customers.
The incident highlights the need for greater awareness and regulation in the cord blood banking industry. While cord blood banking can be a lifesaving option for many families, it is essential that companies operating in this sector act with integrity and transparency.
In conclusion, the consumer commission's order is a significant step towards ensuring that companies act fairly and transparently in their dealings with customers. It also underscores the importance of protecting consumers' rights, especially in sensitive matters such as cord blood banking.
The decision is likely to have implications for the cord blood banking industry as a whole, with companies being held to higher standards of transparency and fairness. As the industry continues to grow, it is essential that companies prioritize the needs and rights of their customers, and act with integrity and transparency in all their dealings.
The couple's victory is a testament to the importance of consumer protection laws and the role that consumer commissions play in upholding these laws. It is a reminder that consumers have rights and that companies must be held accountable for their actions.
The case also highlights the need for greater awareness about cord blood banking and the importance of carefully reviewing contracts and agreements before signing. Parents who are considering cord blood banking should be aware of the terms and conditions of the service, including the company's policies on payment and sample storage.
Ultimately, the consumer commission's decision is a significant step towards promoting fairness and transparency in the cord blood banking industry. It is a reminder that companies must prioritize the needs and rights of their customers, and act with integrity and transparency in all their dealings.
Frequently asked questions
What happened to the newborn's cord blood sample?
The cord blood sample was discarded by Cordlife Sciences India due to delayed payment.
How much did the consumer commission order Cordlife Sciences India to pay?
The company was ordered to pay a total of Rs 2.16 lakh, including a refund of the initial payment and compensation and costs.